Lung Cancer Clinical Trial

Beyond the Lung Cancer Diagnosis: Leveraging the Oncology Clinic Setting for Actively Smoking Family Members

Summary

The purpose of this pilot study is to examine, in an innovative setting, the potential for a lung cancer diagnosis in a loved one to represent a teachable moment for smoking cessation in family members or caregivers who are current smokers. The researchers will identify the willingness and preferred modality for smoking cessation among family members/caregivers in this setting. The researchers will estimate abstinence rates at 4, 8, 12, and 24 weeks..

View Eligibility Criteria

Eligibility Criteria

Patient Inclusion Criteria:

patient with newly diagnosed lung cancer within the last 6 months of initial diagnosis/confirmation of diagnosis at the study sites
Able to provide informed consent
Able to speak and read English

Family Member/Caregiver Participant Criteria:

Family member or caregiver (defined as first degree relative [parent, sibling, child] or person living in the same household)
Family member or caregiver must be a current, active smoker (defined as 10 cigarettes per day for 6 consecutive months).
At least 18 years of age at time of study consent
Able to provide informed consent
Able to speak and read English

Exclusion Criteria:

Currently receiving formal tobacco dependence treatment- Nicotine replacement of any kind, varenicycline or Bupropion.
Medical condition that precludes proposed pharmacotherapy for smoking cessation : Recent (≤ 2 weeks) myocardial infarction , history of underlying arrhythmias , history of serious or worsening angina pectoris, pregnancy and breastfeeding

Study is for people with:

Lung Cancer

Estimated Enrollment:

60

Study ID:

NCT03966807

Recruitment Status:

Active, not recruiting

Sponsor:

Indiana University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 2 Locations for this study

See Locations Near You

IU Health Joe and Shelly Schwarz Cancer Center
Carmel Indiana, 46032, United States
Indiana University Melvin & Bren Simon Cancer Center
Indianapolis Indiana, 46202, United States

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

60

Study ID:

NCT03966807

Recruitment Status:

Active, not recruiting

Sponsor:


Indiana University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.